Literature DB >> 15149722

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

Aina S Lihn1, Jens M Bruun, Gengsheng He, Steen B Pedersen, Peter F Jensen, Bjørn Richelsen.   

Abstract

Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149722     DOI: 10.1016/j.mce.2004.03.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  83 in total

1.  Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; J Christopher Eagon; Samuel Klein
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 2.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 3.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

4.  Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification.

Authors:  Jonathan Golledge; Rumal Jayalath; Lisa Oliver; Adam Parr; Leon Schurgers; Paula Clancy
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

5.  Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.

Authors:  S P Y Wong; M Huda; P English; A Bargiota; J P H Wilding; A Johnson; R Corrall; J H Pinkney
Journal:  Diabetologia       Date:  2005-11-17       Impact factor: 10.122

6.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

7.  Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA).

Authors:  Arianna Maiorana; Chiara Del Bianco; Stefano Cianfarani
Journal:  Rev Diabet Stud       Date:  2007-11-10

8.  Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice.

Authors:  J Østergaard; S Thiel; M Gadjeva; T K Hansen; R Rasch; A Flyvbjerg
Journal:  Diabetologia       Date:  2007-05-01       Impact factor: 10.122

9.  Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

Authors:  Susan A Phillips; Theodore P Ciaraldi; Deborah K Oh; Michelle K Savu; Robert R Henry
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

10.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.